Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1)
Condition: Niemann-Pick Disease, Type C1 Intervention: Drug: Hydroxypropyl-beta-cyclodextrin Sponsor: CTD Holdings, Inc. Not yet recruiting - verified October 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Niemann-Pick Disease | Study